- Home
- ATXG vs GLMD Comparison
ATXG vs GLMD Comparison
Compare ATXG & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATXG | GLMD |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | China | Israel |
| Employees | 112 | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 4.0M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ATXG | GLMD |
|---|---|---|
| Price | $4.27 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.9K | ★ 80.4K |
| Earning Date | 02-13-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.41 |
| 52 Week High | $7.94 | $2.34 |
Technical Indicators
Market Signals| Indicator | ATXG | GLMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 45.01 |
| Support Level | $0.34 | $0.53 |
| Resistance Level | $5.24 | $0.69 |
| Average True Range (ATR) | 0.34 | 0.05 |
| MACD | -0.16 | -0.00 |
| Stochastic Oscillator | 9.49 | 14.51 |
Price Performance
Historical ComparisonAbout ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.